Report cover image

Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Product, By Region, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Nov 12, 2025
Length 140 Pages
SKU # GV20649563

Description

Hyaluronic Acid-based Dermal Fillers Market Summary

The global hyaluronic acid-based dermal fillers market size was estimated to be worth USD 4.47 billion in 2024 and is projected to reach USD 11.00 billion by 2033, growing at a CAGR of 10.5% from 2025 to 2033. The primary factors driving the market growth are the rising demand for non-invasive aesthetic treatment procedures and increasing awareness regarding the application of HA in the beauty segment.

According to the American Society of Plastic Surgeons (ASPS) 2024 report, hyaluronic acid (HA) fillers remain one of the most in-demand minimally invasive treatments, with over 5.3 million procedures performed to enhance facial features, including 1.58 million lip enhancement treatments. In addition, the increased investment in R&D for novel advanced innovations in dermal products is driving the market's growth.

Themarket expansion is majorly influenced by the aging population worldwide. The large economies are experiencing demographic change as the number of people in the older age categories is rising, and the need for beauty products to fight the visible signs of aging and preserve a youthful look is increasing. As a result, there has been a substantial increase in the need for injectable that alleviate in a visible way wrinkles, fine lines, and other skin-related issues caused by aging. According to an article published by Simbo AI, those aged 40-54 comprise almost 49% of all dermal filler procedures, and the 55-69 age group makes up approximately 37% of the treatments. This pattern is indicative of an increasing number of older people opting for less invasive cosmetic treatments, which is expected to drive the adoption of hyaluronic acid dermal fillers. Similarly, as per the Australia's 2023 Intergenerational Report, by 2050, the country's population aged 65 to 84 years is projected to more than double, and the population of those aged 85 years & over is expected to quadruple. This demographic shift is increasing the number of specialized clinics that cater to the needs of the elderly.

Global Hyaluronic Acid-based Dermal Fillers Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global hyaluronic acid dermal fillers market report on the basis of product, application, and region:
  • Product Outlook (Revenue, Million, 2021 - 2033)
  • Single Phase Products
  • Duplex Products
  • Application Outlook (Revenue, Million, 2021 - 2033)
  • Wrinkle Removal
  • Lip Augmentation
  • Rhinoplasty
  • Others
  • Region Outlook (Revenue, Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Russia
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Thailand
  • Australia
  • Singapore
  • Malaysia
  • Taiwan
  • India
  • Vietnam
  • Philippines
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

140 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Hyaluronic Acid-based Dermal Fillers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Hyaluronic Acid-based Dermal Fillers Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Hyaluronic Acid-based Dermal Fillers Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hyaluronic Acid-based Dermal Fillers Market: Product Movement Analysis
4.3. Hyaluronic Acid-based Dermal Fillers Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Single-Phase Product
4.5.1. Single-Phase Product Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Duplex Products
4.6.1. Duplex Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Hyaluronic Acid-based Dermal Fillers Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hyaluronic Acid-based Dermal Fillers Market: Application Movement Analysis
5.3. Hyaluronic Acid-based Dermal Fillers Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Wrinkle Removal
5.5.1. Wrinkle Removal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Lip Augmentation
5.6.1. Lip Augmentation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Rhinoplasty
5.7.1. Rhinoplasty Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Hyaluronic Acid-based Dermal Fillers Market Movement Analysis
6.3. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis by Device Class & End-use
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. North America
6.5.1. North America Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Europe
6.5.5. Europe Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. UK
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement scenario
6.5.6.5. UK Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Germany
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Germany Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. France
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement scenario
6.5.8.5. France Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Italy
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement scenario
6.5.9.5. Italy Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.10. Spain
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Reimbursement scenario
6.5.10.5. Spain Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.11. Denmark
6.5.11.1. Key Country Dynamics
6.5.11.2. Competitive Scenario
6.5.11.3. Regulatory Framework
6.5.11.4. Reimbursement scenario
6.5.11.5. Denmark Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.12. Sweden
6.5.12.1. Key Country Dynamics
6.5.12.2. Competitive Scenario
6.5.12.3. Regulatory Framework
6.5.12.4. Reimbursement scenario
6.5.12.5. Sweden Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.13. Norway
6.5.13.1. Key Country Dynamics
6.5.13.2. Competitive Scenario
6.5.13.3. Regulatory Framework
6.5.13.4. Reimbursement scenario
6.5.13.5. Norway Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.14. Russia
6.5.14.1. Key Country Dynamics
6.5.14.2. Competitive Scenario
6.5.14.3. Regulatory Framework
6.5.14.4. Reimbursement scenario
6.5.14.5. Russia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Japan Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. China Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. India Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. South Korea Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Australia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Thailand Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.8. Singapore
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Reimbursement scenario
6.6.8.5. Singapore Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.9. Malaysia
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. Reimbursement scenario
6.6.9.5. Malaysia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.10. Taiwan
6.6.10.1. Key Country Dynamics
6.6.10.2. Competitive Scenario
6.6.10.3. Regulatory Framework
6.6.10.4. Reimbursement scenario
6.6.10.5. Taiwan Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.11. Vietnam
6.6.11.1. Key Country Dynamics
6.6.11.2. Competitive Scenario
6.6.11.3. Regulatory Framework
6.6.11.4. Reimbursement scenario
6.6.11.5. Vietnam Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.12. Philippines
6.6.12.1. Key Country Dynamics
6.6.12.2. Competitive Scenario
6.6.12.3. Regulatory Framework
6.6.12.4. Reimbursement scenario
6.6.12.5. Philippines Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Brazil Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Argentina Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.4. Mexico
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Mexico Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East & Africa
6.8.1. Middle East & Africa Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. South Africa Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Saudi Arabia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement scenario
6.8.4.5. UAE Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Kuwait Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Allergan
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Galderma LaboratoriesL.P.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Merz Pharmaceuticals
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Genzyme Corporation
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Anika Therapeutics Inc.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. LG Life Sciences
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. LTD (LG Chem)
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Bio plus Co. Ltd.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Sculpt Luxury
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Dermal Fillers Ltd.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Bioxis Pharmaceutical
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Sinclair Pharma Laboratories
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Vivacy
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Bohus Biotech AB
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us